Edition:
United Kingdom

Aradigm Corp (ARDM.OQ)

ARDM.OQ on NASDAQ Stock Exchange Capital Market

1.00USD
8:59pm GMT
Change (% chg)

$-0.10 (-9.09%)
Prev Close
$1.10
Open
$1.06
Day's High
$1.10
Day's Low
$1.00
Volume
4,080
Avg. Vol
6,193
52-wk High
$7.26
52-wk Low
$1.00

Chart for

About

Aradigm Corporation is a pharmaceutical company focused on the development and commercialization of products for the treatment and prevention of severe respiratory diseases. The Company's lead product candidate is Pulmaquin inhaled ciprofloxacin, which is in Phase III clinical trials. It offers AERx pulmonary drug delivery... (more)
No analyst recommendations are available for .

Overall

Beta: 9.62
Market Cap(Mil.): $17.48
Shares Outstanding(Mil.): 15.20
Dividend: --
Yield (%): --

Financials

  ARDM.OQ Industry Sector
P/E (TTM): -- 80.78 29.53
EPS (TTM): -1.11 -- --
ROI: -375.23 -0.25 13.00
ROE: -- -3.01 14.69

Earnings vs. Estimates